ESTEFANÍA
CARRASCO GARCÍA
Hospital General Universitario de Elche
Elche, EspañaPublications en collaboration avec des chercheurs de Hospital General Universitario de Elche (8)
2018
2014
-
Comparative study of 17-AAG and NVP-AUY922 in pancreatic and colorectal cancer cells: Are there common determinants of sensitivity?
Translational Oncology, Vol. 7, Núm. 5, pp. 590-604
-
Resistance to selumetinib (AZD6244) in colorectal cancer cell lines is mediated by p70s6K and RPS6 activation
Neoplasia (United States), Vol. 16, Núm. 10, pp. 845-860
-
Role of receptor tyrosine Kinases and their Ligands in glioblastoma
Cells, Vol. 3, Núm. 2, pp. 199-235
2011
-
Small tyrosine kinase inhibitors interrupt EGFR signaling by interacting with erbB3 and erbB4 in glioblastoma cell lines
Experimental Cell Research, Vol. 317, Núm. 10, pp. 1476-1489
2007
-
Inhibition of Hsp90 function by ansamycins causes downregulation of cdc2 and cdc25c and G2/M arrest in glioblastoma cell lines
Oncogene, Vol. 26, Núm. 51, pp. 7185-7193
2006
-
Cyclin D3 is down-regulated by rapamycin in HER-2-overexpressing breast cancer cells
Molecular Cancer Therapeutics, Vol. 5, Núm. 9, pp. 2172-2181
2005
-
Histone deacetylase inhibitors induced caspase-independent apoptosis in human pancreatic adenocarcinoma cell lines
Molecular Cancer Therapeutics, Vol. 4, Núm. 8, pp. 1222-1230